Related references
Note: Only part of the references are listed.MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer
Lu Zhang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
T-cell acute lymphoblastic leukemia from miRNA perspective: Basic concepts, experimental approaches, and potential biomarkers
Monika Drobna et al.
BLOOD REVIEWS (2018)
Pediatric T-Cell Acute Lymphoblastic Leukemia
Kristina Karrman et al.
GENES CHROMOSOMES & CANCER (2017)
MicroRNA-34a: A Versatile Regulator of Myriads of Targets in Different Cancers
Ammad Ahmad Farooqi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Co-targeting of DNA, RNA, and protein molecules provides optimal outcomes for treating osteosarcoma and pulmonary metastasis in spontaneous and experimental metastasis mouse models
Chao Jian et al.
Oncotarget (2017)
Comprehensive miRNA expression profiling in human T-cell acute lymphoblastic leukemia by small RNA-sequencing
Annelynn Wallaert et al.
SCIENTIFIC REPORTS (2017)
Putting p53 in Context
Edward R. Kastenhuber et al.
CELL (2017)
miRNAs: micro-managers of anticancer combination therapies
Judy R. van Beijnum et al.
ANGIOGENESIS (2017)
Homeobox protein TLX3 activates miR-125b expression to promote T-cell acute lymphoblastic leukemia
Laurent Renou et al.
BLOOD ADVANCES (2017)
Management of adults with T-cell lymphoblastic leukemia
David I. Marks et al.
BLOOD (2017)
Differential role of microRNAs in the pathogenesis and treatment of Esophageal cancer
Maryam Hemmatzadeh et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
The role of microRNAs in colorectal cancer
Ali Mohammadi et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
Cancer chemoresistance; biochemical and molecular aspects: a brief overview
Saeed Kachalaki et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
High miR-34a expression improves response to doxorubicin in diffuse large B-cell lymphoma
Sara Correia Marques et al.
EXPERIMENTAL HEMATOLOGY (2016)
Low levels of Caspase-3 predict favourable response to 5FU-based chemotherapy in advanced colorectal cancer: Caspase-3 inhibition as a therapeutic approach
L. Flanagan et al.
CELL DEATH & DISEASE (2016)
miR-590 promotes cell proliferation and invasion in T-cell acute lymphoblastic leukaemia by inhibiting RB1
Mei-hua Miao et al.
ONCOTARGET (2016)
How I treat T-cell acute lymphoblastic leukemia in adults
Mark R. Litzow et al.
BLOOD (2015)
Aggravated bone density decline following symptomatic osteonecrosis in children with acute lymphoblastic leukemia
Marissa A. H. den Hoed et al.
HAEMATOLOGICA (2015)
Acute Lymphoblastic Leukemia in Children
Stephen P. Hunger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Aggravated bone density decline following symptomatic osteonecrosis in children with acute lymphoblastic leukemia
Marissa A. H. den Hoed et al.
HAEMATOLOGICA (2015)
Mir-34: A New Weapon Against Cancer?
Gabriella Misso et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2014)
Friend or foe: the role of microRNA in chemotherapy resistance
Haoran Li et al.
ACTA PHARMACOLOGICA SINICA (2013)
siRNA-mediated Silencing of Survivin Inhibits Proliferation and Enhances Etoposide Chemosensitivity in Acute Myeloid Leukemia Cells
Hadi Karami et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
microRNA-34a Sensitizes Lung Cancer Cell Lines to DDP Treatment Independent of p53 Status
Xi Wang et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2013)
Relapsed childhood acute lymphoblastic leukaemia
Deepa Bhojwani et al.
LANCET ONCOLOGY (2013)
MicroRNA-34a Modulates Chemosensitivity of Breast Cancer Cells to Adriamycin by Targeting Notch1
Xiu-juan Li et al.
ARCHIVES OF MEDICAL RESEARCH (2012)
miR-34a is downregulated in cis-diamminedichloroplatinum treated sinonasal squamous cell carcinoma patients with poor prognosis
Takenori Ogawa et al.
CANCER SCIENCE (2012)
Targeted BCL2 inhibition effectively inhibits neuroblastoma tumour growth
Fieke Lamers et al.
EUROPEAN JOURNAL OF CANCER (2012)
Enhanced Radiosensitivity and Chemosensitivity of Breast Cancer Cells by 2-Deoxy-D-Glucose in Combination Therapy
Fahimeh Aghaee et al.
JOURNAL OF BREAST CANCER (2012)
Improved Survival for Children and Adolescents With Acute Lymphoblastic Leukemia Between 1990 and 2005: A Report From the Children's Oncology Group
Stephen P. Hunger et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Marco Gerlinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
A cooperative microRNA-tumor suppressor gene network in acute T-cell lymphoblastic leukemia (T-ALL)
Konstantinos J. Mavrakis et al.
NATURE GENETICS (2011)
High expression of BCL-2 predicts favorable outcome in non-small cell lung cancer patients with non squamous histology
Valsamo K. Anagnostou et al.
BMC CANCER (2010)
miR-34a as part of the resistance network in chronic lymphocytic leukemia
Thorsten Zenz et al.
BLOOD (2009)
Doxorubicin: The Good, the Bad and the Ugly Effect
Cristina Carvalho et al.
CURRENT MEDICINAL CHEMISTRY (2009)
miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities
M. Mraz et al.
LEUKEMIA (2009)
MicroRNA miR-34 Inhibits Human Pancreatic Cancer Tumor-Initiating Cells
Qing Ji et al.
PLOS ONE (2009)
Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study
K. Nguyen et al.
LEUKEMIA (2008)
Overexpression of caspase-3s splice variant in locally advanced breast carcinoma is associated with poor response to neoadjuvant chemotherapy
Frederique Wegran et al.
CLINICAL CANCER RESEARCH (2006)
Low-dose doxorubicin-induced necrosis in Jurkat cells and its acceleration and conversion to apoptosis by antioxidants
K Sugimoto et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Share Paper
